Background: Fifteen percent of small for gestational age (SGA) children remain short and undergo thyroid axis evaluations. Methods: We analyzed data on thyroid assessment of 58 SGA children. Five had primary autoimmune hypothyroidism. In the remaining 53 patients, TSH, free T4 (FT4), antithyroid antibodies and 90-min TRH test results were analyzed. Patients were grouped into G1 (n = 27; normal) and G2 (n = 26; abnormal) according to their response to the TRH test compared with 30 normal children. Results: No differences were found in chronological age, gestational age, or birth weight standard deviation score (SDS) between groups. G2 showed higher SDS BMI at consultation (p < 0.05). FT4 (ng/dl) levels were similar in all groups, while basal TSH levels were statistically different in G2 compared with G1 and controls. In 21 G2 patients treated with thyroxine, FT4 levels did not change, TSH normalized, BMI SDS and height remained unchanged. Conclusion: These data suggest that in SGA short children thyroid abnormalities may occur. Some of them may be due to a different setting of the hypothalamic-hypophyseal-thyroid axis during intrauterine life. Intrauterine growth retardation may permanently influence endocrine systems by affecting their programming during development. Further follow-up is needed to confirm these findings and to assess their natural history and potential clinical impact.

1.
Gardosi J: New definition of small for gestational age based on foetal growth potential. Horm Res 2006;65(suppl 3):15–18.
2.
Saenger P, Czernichow P, Hughes I, Reiter E: Small for gestational age: short stature and beyond. Endocr Rev 2007;28:219–251.
3.
Lee P, Chernausek SD, Hokken-Koelega AC, Czernichow P: International small for gestational age advisor board consensus development conference statement: management of short children born small for gestational age. Paediatrics 2001;111:1253–1261.
4.
Job JC, Rolland A: Natural history of intrauterine growth retardation: pubertal growth and adult height. Arch Fr Paediatr 1986;43:301–306.
5.
Fitzhardinge PM, Inwood S: Long-term growth in small for date children. Acta Paediatr Scand Suppl 1989;349:27–33.
6.
Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck Keizer-Schrama SM, Drop LS: Children born small for gestational age: do they catch up? Paediatr Res 1995;38:267–271.
7.
Albertson Wikland K, Boguzsewki M, Kalberg J: Children born small for gestational age: postnatal growth and hormonal status. Horm Res 1998;49(suppl 2):7–13.
8.
Albertsson Wikland K, Kalberg J: Postnatal growth of children born small for gestational age. Acta Paediatr Scand Suppl 1997;423:193–195.
9.
Albertsson Wikland K, Kalberg J: Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Scand Suppl 1994;399:64–70.
10.
Chaussian JL, Colle M, Ducret JP: Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatr Scand Suppl 1994;399:72–73.
11.
Kalberg J, Albertsson-Wikland K: Growth in full term small for gestational age infants: from birth to final height. Pediat Res 1995;38:733–739.
12.
Bryan SM, Hindmarsh PC: Normal and abnormal fetal growth. Horm Res 2006;65 (suppl 3):19–27.
13.
Achermann J, Cameron F, Cowell C, Johnston L, Rose SR: ESPE 2006. 45th Annu Meet Eur Soc Pediatr Endocrinol, Rotterdam, June–July 2006. Amersfoort, Medical Forum International, 2006.
14.
Cianfarani S, Ladaki C, Geremia C: Hormonal regulation of postnatal growth in children born small for gestational age. Horm Res 2006;65(suppl 3):70–74.
15.
Cianfarani S, Maiorana A, Geremia C, Scire G, Spadoni GL, Germani D: Blood glucose concentrations are reduced in children born small for gestational age (SGA) and thyroid-stimulating hormone levels are increased in SGA with blunted postnatal catch-up growth. J Clin Endocrinol Metab 2003;88:2699–2705.
16.
Radetti G, Renzullo L, Gottardi E, D’Addato G, Messner H: Altered thyroid and adrenal function in children born at term and preterm small for gestational age. J Clin Endocrinol Metab 2004;89:6320–6324.
17.
Radetti G, Fanolla A, Pappalardo L, Gottardi E: Prematurity may be a risk factor for thyroid dysfunction in childhood. J Clin Endocrinol Metab 2007;92:155–159.
18.
Lubchenko LO, Hansman C, Dressler M, Boyd R: Intrauterine growth as estimated from liveborn birth weight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793–800.
19.
Lejarraga: Guías para la evaluación del crecimiento, 2 ed. Comité Nacional de Crecimiento y Desarrollo, Sociedad Argentina de Pediatría, 2001.
20.
Cole T, Freeman JV, Preece MA: Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25–29.
21.
Gruñeiro Papendieck L, Chiesa A, Martinez A, Heinrich JJ, Bergadá C: Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 1998;50:252–257.
22.
Rose SR, Manasco PK, Pearce S, Nisula DC: Hypothyroidism and deficiency of the nocturnal thyrotrophic surge in children with hypothalamic-pituitary disorders. J Clin Endocr Metab 1990;70:1750–1755.
23.
Gruñeiro Papendieck L, Chiesa A, Mendez V, Bengolea S, Prieto L: TSH neonatal levels as an index of iodine sufficiency: differences related to time of screening sampling and methodology. Horm Res 2004;62:272–276.
24.
Crofton P, Tepper L, Kelnar Ch: Evaluation of the thyrotrophin-releasing hormone stimulation test in paediatric clinical practice. Horm Res 2008;69:53–59.
25.
Hollenberg A: The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid 2008;18:131–139.
26.
Lechan RM, Fekete C: The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 2006;153:209–235.
27.
Kilby MD, Gittoes N, McCabe C, Verhaeg J, Franklyn JA: Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol (Oxf) 2000;53:469–477.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.